Podcasts about Abstract

What is Reliability? Abstract What is the definition of reliability? Outside of the field of reliability, who defines it or what a failure is? Join Mojan and Fred as they explore how reliability is perceived across the product development ecosystem—from customers to suppliers to design engineers—and why the classic “but it met the spec!” defense […]

Olga Goriunova ⁠is a cultural theorist who works at the intersection of technology, media, philosophy, and aesthetics. Born in the Soviet Union, she is now based in the UK. Her research is transdisciplinary and engages questions of subjectivation, art and computing across different scales and modes of operation.In this interview, we talk about her latest book, I⁠deal Subjects: Abstract People of AI.⁠ In it, she explores how data and artificial intelligence abstract people into new genres of “subjects,” mapping the horizon of individual and societal possibility.The idea of “ideal subjects” can be useful for designers and user researchers, especially when trying to understand—and question—the way our online data is produced, relates back to us and models our future.She is helping us to question:  - What kind of "subject" is created through data? - How does data based representation attempt to match a human being? - How come that these data-based abstractions are able to engage our desire and thus direct our becoming in relation to their modelled prescriptions? This episode is part of several lists: Investigación en diseño, Reino Unido y diseño, Rusia y diseño, D&D in English, Filosofía y diseño, Arte y diseño social, and AI en UX. While many of the list titles are in Spanish, the content itself is trilingual. Some episodes are in English, others in Spanish or Portuguese. The list D&D in English brings together all the English-language episodes, and it now includes nearly 50 interviews.

Abstract: Members of the 1834 Zion's Camp expedition inspected a large mound along the Illinois River where a skeleton was uncovered and Joseph Smith had a revelatory experience identifying the individual as Zelph. Recent archeological excavations place the revelation in a chronological and ancient cultural context that now allows additional verification and interpretation of this revelatory event. In addition, with this new information, it is possible to determine whether the individual and location can be interpreted as being a part of the Book of Mormon culture and geography. The post A Scientific Evaluation of the Zelph Revelation first appeared on The Interpreter Foundation.

Cancer is increasingly recognized as a major global health challenge, yet for people living through war, displacement, and humanitarian crises, access to even basic oncology services can be difficult or impossible. While emergency responses typically focus on trauma care, infectious diseases, and immediate survival needs, cancer care remains largely absent from many humanitarian health programs. A review paper on this topic was published in Volume 17 of Oncotarget titled “Cancer without borders: Policy frameworks for oncology care in humanitarian and conflict settings.” The study was led by first and corresponding author Pragnesh Parmar, with Gunvanti Rathod as co-author, both from AIIMS Bibinagar, Telangana, India. Full blog - https://www.oncotarget.org/2026/06/03/cancer-care-often-overlooked-in-humanitarian-crises/ Paper DOI - https://doi.org/10.18632/oncotarget.28856 Correspondence to - Pragnesh Parmar - drprag@gmail.com; (ORCID: orcid.org/0000-0002-8402-8435) Abstract video - https://www.youtube.com/watch?v=zXlhIBZyJ6Q Sign up for free Altmetric alerts about this article - https://oncotarget.altmetric.com/details/email_updates?id=10.18632%2Foncotarget.28856 Subscribe for free publication alerts from Oncotarget - https://www.oncotarget.com/subscribe/ Keywords - cancer, cancer care, humanitarian crisis, tele-oncology, global health policy, oncology triage To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us on social media: Facebook - https://www.facebook.com/Oncotarget/ X - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/@OncotargetJournal LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Spotify - https://open.spotify.com/show/0gRwT6BqYWJzxzmjPJwtVh MEDIA@IMPACTJOURNALS.COM

Chapters 1, & 3 – Abstract of Systematic Theology by James Petigru Boyce Liberty Church

BUFFALO, NY — June 3, 2026 — A new #research paper was #published in Volume 18 of Aging-US on May 15, 2026, titled “Extracellular vesicles released by senescent myoblasts affect recipient cells via miRNA-target interactions.” The study was led by first author Michael Kamal from the Department of Kinesiology at McMaster University and corresponding author Gianni Parise from the same university. As people age, skeletal muscle gradually loses strength, size, and regenerative capacity. Scientists have increasingly linked these changes to cellular senescence—a state in which damaged cells permanently stop dividing but remain metabolically active. These senescent cells release a complex mixture of signaling molecules known as the senescence-associated secretory phenotype (SASP), which can influence neighboring cells and contribute to tissue dysfunction. In this study, the researchers investigated whether extracellular vesicles (EVs)—tiny membrane-bound particles released by cells—play a role in this process. Specifically, they examined EVs released by senescent muscle precursor cells, known as myoblasts, and analyzed the microRNAs (miRNAs) carried within these vesicles. The team found that senescent myoblasts released factors that impaired normal muscle cell development. When healthy muscle cells were exposed to signals from senescent cells, the resulting muscle fibers became significantly smaller and displayed increased expression of genes associated with cellular stress and senescence. Further analysis revealed that EVs released by senescent myoblasts carried a distinct set of miRNAs. The researchers identified 22 significantly altered miRNAs, including several previously linked to cellular senescence, such as miR-34a, miR-34b, miR-34c, and miR-22. The study also identified miR-301a-3p as a potentially novel senescence-associated miRNA. Full press release - https://aging-us.net/2026/06/03/senescent-muscle-cells-send-molecular-messages-that-may-contribute-to-age-related-muscle-decline/ DOI - https://doi.org/10.18632/aging.206379 Corresponding author - Gianni Parise - pariseg@mcmaster.ca Abstract video - https://www.youtube.com/watch?v=HKBbraYg8ew Sign up for free Altmetric alerts about this article - https://aging.altmetric.com/details/email_updates?id=10.18632%2Faging.206379 Subscribe for free publication alerts from Aging - https://www.aging-us.com/subscribe-to-toc-alerts Keywords - aging, cellular senescence, extracellular vesicles, myoblasts, miRNA, multi-omics To learn more about the journal, please visit https://www.Aging-US.com​​ and connect with us on social media at: Bluesky - https://bsky.app/profile/aging-us.bsky.social ResearchGate - https://www.researchgate.net/journal/Aging-1945-4589 X - https://twitter.com/AgingJrnl Facebook - https://www.facebook.com/AgingUS/ Instagram - https://www.instagram.com/agingjrnl/ LinkedIn - https://www.linkedin.com/company/aging/ Reddit - https://www.reddit.com/user/AgingUS/ Pinterest - https://www.pinterest.com/AgingUS/ YouTube - https://www.youtube.com/@Aging-US Spotify - https://open.spotify.com/show/1X4HQQgegjReaf6Mozn6Mc MEDIA@IMPACTJOURNALS.COM

BUFFALO, NY – June 2, 2026 – A new #research paper was #published in Volume 17 of Oncotarget on May 20, 2026, titled “Microenvironmental CTHRC1 has a pro-tumorigenic role in colorectal cancer.” The study was led by first author Haylee Duval from the Center for Molecular Medicine at the MaineHealth Institute for Research and the Graduate School of Biomedical Science and Engineering at the University of Maine. The study's corresponding authors were Sergey Ryzhov, Volkhard Lindner, and Michaela R. Reagan, who are affiliated with the Center for Molecular Medicine at the MaineHealth Institute for Research, the Graduate School of Biomedical Science and Engineering at the University of Maine, and Tufts University School of Medicine. Colorectal cancer remains one of the leading causes of cancer-related deaths worldwide. While much research has focused on cancer cells themselves, growing evidence suggests that the tumor microenvironment—the network of surrounding stromal cells, immune cells, and extracellular components—plays a critical role in determining how tumors grow and spread. In this study, researchers investigated collagen triple helix repeat containing 1 (CTHRC1), a secreted protein previously associated with poor outcomes in several cancer types. Although CTHRC1 is frequently detected in tumor-associated stroma, its precise role within the colorectal cancer microenvironment has remained unclear. To address this question, the team used a genetically engineered mouse model lacking CTHRC1 and compared tumor development with that of normal mice after colorectal cancer cells were introduced. The results consistently showed that the absence of host-derived CTHRC1 significantly reduced tumor growth. Across three independent experimental cohorts, mice lacking CTHRC1 developed substantially smaller tumors than their normal counterparts. In addition, survival improved markedly. The median survival of mice with normal CTHRC1 expression was 28 days after tumor inoculation, compared with 69 days in CTHRC1-deficient mice. The researchers also found evidence that CTHRC1 influences anti-tumor immunity. Mice lacking CTHRC1 had higher percentages of CD3-positive T cells in both tumors and spleens, suggesting a more active immune response against cancer. At the same time, they exhibited reduced levels of certain myeloid immune cells associated with immune suppression. Importantly, the investigators confirmed that the colorectal cancer cells themselves did not produce detectable CTHRC1. Instead, the protein was found primarily in fibroblasts and other stromal components surrounding the tumor. This finding indicates that the tumor-promoting effects originated from the tumor microenvironment rather than from the cancer cells directly. Histological analyses further revealed striking differences in tumor structure. Tumors from CTHRC1-deficient mice contained fewer cells and showed evidence of regression, while tumors in normal mice remained densely cellular and continued to expand. Full press release - https://www.oncotarget.com/news/pr/protein-in-tumor-microenvironment-found-to-promote-colorectal-cancer-growth-and-immune-evasion/ DOI - https://doi.org/10.18632/oncotarget.28878 Correspondence to: Sergey Ryzhov - Sergey.Ryzhov@mainehealth.org; Volkhard Lindner- Volkhard.Lindner@mainehealth.org; Michaela R. Reagan - Michaela.Reagan@mainehealth.org Abstract video - https://www.youtube.com/watch?v=gTbYy6vGd7E To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us: Facebook - https://www.facebook.com/Oncotarget/ X - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/@OncotargetJournal LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Spotify - https://open.spotify.com/show/0gRwT6BqYWJzxzmjPJwtVh MEDIA@IMPACTJOURNALS.COM

In this special episode of Takeaway Chinese, we're going to learn how to say "abstract" in Chinese.

The Emperor Julian with Jeremy SwistWe are thrilled to welcome Assistant Professor Jeremy Swist back to the show to discuss all things emperor Julian! Julian's rule as Roman emperor was short, but it also created quite a stir because Julian was keen to turn Rome away from Christianity and to bring back the paganism. How did he do it? Why did he do it? And what's the legacy that he left behind? We consider the details.Jeremy Swist has a PhD in Classics from the University of Iowa, and his research interests include imperial Greek and Roman historiography and rhetoric, late antiquity, classical reception in heavy metal music. He is currently Assistant Professor of Classical Studies at Michigan State University. Jeremy has published and presented extensively, and he has a particular interest in the intersection of heavy metal music and the classical world - we suggest you check out his blog, Heavy Metal Classicist, or our previous episode with him to find out more. In 2024, he translated and produced a dramatic reading of the Emperor Julian's Symposium of the Caesars, which starred some of the finest podcasters and actors in the WORLD! (Maybe us)The Emperor Julian, who ruled Rome between 361 and 363 CE, is one of Jeremy's great passions, and we are thrilled to talk to him about his new volume on this unusual ruler. The book is published by Oxford University Press and is entitled Julian Augustus: Platonism, Myth, and the Refounding of Rome.Abstract from Oxford University Press“The Roman emperor Julian employed both words and deeds to return the empire to paganism and reverse Christianization, inspired by his conversion to the Neoplatonic philosophy and radical pagan Hellenism of Iamblichus, and promoted by his own production of Greek literature. These works present a coherent vision of the providentially guided history and destiny of Rome as a series of (re)foundations enacted by rulers such as Romulus, Numa, and Augustus. Julian offers an Iamblichean approach to interpreting Roman legends, Platonic allegories, and myths of his own creation to articulate his own role in the refounding of the empire. Approaching the wider examination of Julian's imperial self-image on these terms ends up nuancing and challenging common assumptions influenced by the rhetoric of his contemporary proponents. In his reverence for the gods and for philosophy, the emperor's self-construction embraces the identities of a statesman and solider more than philosopher, Roman more than Greek, and mere human rather than semi-divine being. Julian's unique positionality as emperor let him invert the conventions of panegyric whereby rulers equal and surpass the demigods and heroes of myth and history. While distancing himself from the ideal models of virtue and founding that inspire him, he adopts a different set of exemplary figures as mirrors of himself. Statesmen such as Pericles and Scipio, and especially Augustus, serve as precedents for Julian's more realistic conception of his role in refounding the empire, as student and champion of philosophers, guardian of law and tradition, and servant of the gods.”The return to the old godsJulian's rule was short but it left quite an impact. We chat with Jeremy about some of the ideas Julian put forward about Rome, the foundation stories that underpinned its self-definition, and what might have been if weren't for an unfortunate spear that wounded Julian and ended his life just two years into his reign.Sound CreditsOur music is by the superb Bettina Joy de Guzman.For our full show notes and edited transcripts, head on over to https://partialhistorians.com/Support the showPatreonKo-FiRead our booksRex: The Seven Kings of RomeYour Cheeky Guide to the Roman Empire Hosted on Acast. See acast.com/privacy for more information.

All links here: ⁠https://hunterwilliamshealth.com/linksTimestamps:00:00 Intro01:00 Why I'm making this video04:00 The plan: peptides with direct anti-cancer evidence06:02 AOD-9604 and HGH Frag 176-19107:42 BPC-15709:54 DSIP (Delta Sleep Inducing Peptide)11:08 Epitalon12:30 Follistatin 34413:30 GHK-Cu14:36 Kisspeptin15:58 KPV17:18 LL-3718:46 Melanotan 219:58 MOTS-c21:12 Retatrutide22:34 Semaglutide23:40 SS-3124:38 Thymalin25:26 Thymosin Alpha-127:00 Tirzepatide27:30 VIP (Vasoactive Intestinal Peptide)28:06 Bottom line and closing thoughtsDescriptionIf you spend any time in the peptide social media world, you've heard it. "Peptides cause cancer." It's the easiest way to scare someone off something, and a lot of people do it without ever showing you a single study.So I went and pulled the studies. In this video I walk through every peptide on the popular research peptide list that actually has direct anti-cancer evidence in the published literature. Not theory. Not mechanism guesses. Actual studies in cells, animals, and in some cases, humans.You'll see what the research says about BPC-157, GHK-Cu, Epitalon, KPV, LL-37, Thymosin Alpha-1, MOTS-c, semaglutide, tirzepatide, retatrutide, and a handful more. Some of this evidence is strong. Some is preliminary. I'm honest about both.This is not medical advice and I'm not telling you peptides cure cancer. That's not what the data says and that's not what I'm claiming. What I am saying is that the next time someone hits you with a 60 second clip telling you peptides cause cancer, you'll have something more substantial to weigh it against.All study links below.

Let's practice some common Spanish abstract nouns, including nombre, tipo, historia, and poco. Practice all of today's Spanish for free at LCSPodcast.com/74

Interactive social media site Status announced Tuesday $17 million in combined seed and Series A funding, with investors including General Catalyst, YC, LightShed Ventures, and Abstract. Also, Stilta announced Tuesday a $10 million seed round led by Andreessen Horowitz. Other investors in the round include YC and operators from companies like OpenAI, Legora, and Lovable. Learn more about your ad choices. Visit podcastchoices.com/adchoices

In this episode of Diving Into Diets on Bovine Science with BCI, Dr. Brad White and Dr. Todd Gunderson discuss a 2026 study on the high prevalence of bovine leukemia virus in cow-calf operations, implications for cow reproduction, culling, and calf weight. The conversation concludes there is not a great association between culling risk and pregnancy status associated with the ELISA test. Read the article here

Where Peter is? Turning your son in to justice? Abstract religion? Join us for Open Line Monday with Fr. John Trigilio.

This is a special episode about Abstract Wikipedia with James Forrester, Principal Software Engineer and Tech Lead for Abstract Wikipedia, Wikimedia Foundation. We refer to the previous episode about Abstract Wikipedia. All episodes in English (podcast feed) Credits The music and sound clips are from Surf Shimmy by Kevin MacLeod (incompetech.com) [CC BY 3.0], via Wikimedia Commons. Image: Abstract-Wikipedia-favicon.svg, Wikimedia Foundation, Public domain. Discuss the episode on the project’s talk page. The episode is also available on Wikimedia Commons.

This week, Wes and Todd talk with Colorado Springs Artist, Jes Moran. Jes discusses her engagement with art as a child, growing up in Wisconsin, altering clothes & studying apparel design, her compulsion to make, loving process, having an intentional art practice the past five years, creative ideas, some of the other creative pursuits that she explored before doing the work she does now, being self-taught, learning to trust herself, her process, being fearless, quilts, sewing, what art does for her, letting go, her older work, titles, negative space, abstract art, experimentation & exploration, finding her voice, writing, space, memories, family, vulnerability, self-doubt, routine, sacrifices, potato chips, color, her new work, her show at Auric in June, being seen & valued, the support of her family, the Colorado Springs art community, and her idea of perfect happiness.Join us for a wonderful conversation with Jes Moran!Check out Jes Moran's exquisite work at www.jesmoran.comFollow Jes Moran on social media:Instagram - www.instagram.com/jesdmoran/ - @jesdmoranJes' exhibition “Seam Shift: painting through construction” will be on display at Auric Gallery through the month of June. Opening reception June 5th.  For more information go to www.auricgallery.comSend us Fan MailFollow us on Instagram:@tenetpodcast - www.instagram.com/tenetpodcast/@wesbrn - www.instagram.com/wesbrn/@toddpiersonphotography - www.instagram.com/toddpiersonphotography/ Follow us on Facebook:www.facebook.com/TenetPodcast/Email us at todd@toddpierson.com If you enjoyed this episode or any of our previous episodes, please consider taking  a moment and leaving us a review on your favorite podcast platform.Thanks for listening! 

Most communication is misunderstood by default.I break down why INFPs and ISTJs keep missing each other even when they care deeply, and what you can actually do to fix it. If you've ever felt like your partner just doesn't “get” you, this will clarify what's happening under the surface.In this video, I go into how communication gets filtered through personal meaning, why abstract ideas and feelings often get distorted, and how cognitive functions create friction in relationships. I also show how INFPs can adjust their approach without betraying themselves.You'll learn:Why “understanding” is often an illusionHow INFP and ISTJ functions clash in communicationWhat role assumptions and mind-reading playHow to use feedback and clarity to reduce conflictA simple shift using your tertiary functionThe exact question that cuts through confusionIf you want better communication, less frustration, and more alignment in your relationship, this gives you a practical way forward.If this helped, subscribe for more on personality, relationships, and leveling up your inner characters.Like the video if you've experienced this. It helps more people see it.Drop a comment with your experience. INFP, ISTJ, or something else.0:00 Most communication is miscommunication0:32 Why your words get interpreted differently1:28 Abstract ideas always get distorted2:15 Stop assuming they understand you3:05 Mind reading is breaking your relationship4:05 Take responsibility for being understood5:05 INFP cognitive functions (Soul, Explorer)6:35 ISTJ cognitive functions (Guardian, Commander)8:10 Why INFP vs ISTJ naturally clash9:45 Why your advice feels wrong to them11:20 Why their advice feels wrong to you12:45 The “function mismatch” problem13:40 Fix #1: Use your Guardian (Si)14:40 Fix #2: Get specific and clarify15:40 The question that fixes misunderstanding

Artur Dron is a 25-year-old Ukrainian poet, essayist, and combat veteran. Born in Ivano-Frankivsk Oblast in western Ukraine. Graduated from the Department of Journalism at Ivan Franko National University of Lviv. Before the full-scale invasion, worked as event manager at The Old Lion Publishing House in Lviv — the publisher that would later issue Hemingway Knows Nothing. Saw combat across Donetsk, Kharkiv, and Zaporizhzhia oblasts. Seriously wounded in October 2024 by an anti-personnel mine. Endured multiple surgeries and a nerve transplant after shrapnel injuries. Demobilised in July 2025 due to disability — discharged on 4 July 2025, completing service that began on 2 March 2022. His poetry has been translated into at least ten languages.----------BOOKS: Dormitory №6 (2020) We Were Here (2023)Hemingway Knows Nothing (2025)LINKS:https://warpoetryukraine.org/https://pen.org.ua/en/members/dron-arturhttps://ukraineworld.org/en/articles/stories/poetry-ukrainianhttps://chytomo.com/en/review-of-artur-dron-s-book-hemingway-knows-nothing/https://www.arrowsmithpress.com/journal/artur-dronhttps://book.artarsenal.in.ua/en/guest-2023/artur-dron-2/To purchase Artur's book of poetry in UK: https://www.jantarpublishing.com/product-page/we-were-here----------SUPPORT THE CHANNEL:https://www.buymeacoffee.com/siliconcurtainhttps://www.patreon.com/siliconcurtainhttps://www.gofundme.com/f/scaling-up-campaign-to-fight-authoritarian-disinformation----------ACTIVE CAMPAIGN:We are raising funds for 5 of 15 Vampire DronesSilicon Curtain for Kupiansk Vampires. Dzyga's Paw, together with Jonathan Fink, is joining forces to raise $40,000 to provide the Khartiia Brigade with Vampire Drones.https://dzygaspaw.com/silicon-curtain-for-kupiansk-vampiresThese heavy bombers are designed to destroy manpower and equipment, as well as for remote mining. The Vampire UAV, manufactured by Skyfall, has proven itself to be one of the most effective weapons in the Kupiansk direction. Skyfall is one of Ukraine's largest defense tech companies, producing Vampire bomber drones, various modifications of Shrike FPV drones, P1-SUN, Shahed drone interceptors, communication systems, and components.https://dzygaspaw.com/silicon-curtain-for-kupiansk-vampires----------TRUSTED CHARITIES ON THE GROUND:Car4Ukrainehttps://car4ukraine.com/en-US/campaignsDzyga's Pawhttps://dzygaspaw.com/projectsSuperhumans - Hospital for war traumashttps://superhumans.com/en/UNBROKEN - Treatment. Prosthesis. Rehabilitation for Ukrainians in Ukrainehttps://unbroken.org.ua/Come Back Alivehttps://savelife.in.ua/en/Chefs For Ukraine - World Central Kitchenhttps://wck.org/relief/activation-chefs-for-ukraineUNITED24 - An initiative of President Zelenskyyhttps://u24.gov.ua/Serhiy Prytula Charity Foundationhttps://prytulafoundation.orgNGO “Herojam Slava”https://heroiamslava.org/----------PLATFORMS:Substack: https://substack.com/@siliconcurtainTwitter: https://twitter.com/CurtainSiliconLinkedin: https://www.linkedin.com/in/finkjonathan/Podcast: https://open.spotify.com/show/4thRZj6NO7y93zG11JMtqm----------

We chatted with Montreal-based artist Avril Jensen about writing an abstract song from personal experience. Download the lyrics to Dog (everybody learns) to follow along. We talked about: Songwriting Challenge 2026: Write a Traditional Country Song Writing musically interesting melodies that are still catchy Writing the lyrics based on personal experience with actual dogs, but maybe it's also a metaphor for a toxic relationship 80s French Canadian band The Box Does music theory get in your way of keeping things simple?… Read the rest

Peter A. Kirby is a world-renowned independent researcher, investigative author, and activist specializing in deep dives into suppressed and controversial subjects. His groundbreaking work on geoengineering and weather modification has earned him international recognition. Peter is the author of "Chemtrails Exposed: A New Manhattan Project", widely regarded as the most comprehensive book on the subject. He hosts The Abstract on Rumble and provides sharp social commentary on TruthSocial. His research has been translated into every major language and featured across major alternative media platforms.Watch the Cornerstone Forum 26'https://shaunnewmanpodcast.substack.com/Silver Gold Bull Links:Website: https://silvergoldbull.ca/Email: SNP@silvergoldbull.comText Grahame: (587) 441-9100Bow Valley Credit UnionBitcoin: www.bowvalleycu.com/en/personal/investing-wealth/bitcoin-gatewayEmail: welcome@BowValleycu.com Get your voice heard: Text Shaun 587-217-8500

This episode covers a wide range of topics across betting, prediction markets, and probabilistic thinking. We start with the Brendan Sorsby situation after reports surfaced about a major gambling-related issue involving the Texas Tech QB, including over 10,000 bets placed dating back to 2022. The conversation focuses on what this means for gambling integrity in college sports and the broader responsibility discussion that comes with it. From there, the panel reacts to Isaac Rose-Berman's recent article on prediction markets and the way they are positioned as an alternative to traditional sportsbooks. The discussion explores whether that framing is accurate, how these platforms actually generate profit, and what bettors often misunderstand about their structure. The group also breaks down a viral take from Plus EV Analytics on parlay thinking and how human intuition struggles with probability when outcomes are layered together. Host Jacob Gramegna is joined throughout the episode by Joey Knish, Isaac Rose-Berman, and Chris Dierkes (Flupnolide), a trader at Novig, with all four contributors involved in the full discussion across gambling, markets, and bettor psychology.

BUFFALO, NY – April 29, 2026 – A new #research paper was #published in Volume 17 of Oncotarget on April 28, 2026, titled “Targeted therapeutics and U.S. population-level mortality trends in multiple myeloma: A SEER-based analysis from 1975 to 2023.” The study was led by first and corresponding author Navkirat Kahlon from the Mass General Cancer Center at Wentworth-Douglass Hospital, in collaboration with researchers from multiple U.S. institutions. In this study, the researchers examined how mortality trends in multiple myeloma have changed in the United States over nearly five decades, using population-level data from the SEER database. Multiple myeloma, a cancer of plasma cells, has historically been associated with poor survival outcomes, but treatment options have evolved dramatically over time. The analysis revealed a clear shift in mortality trends that closely parallels major therapeutic advances. Between 1975 and the mid-1990s, mortality rates steadily increased, reflecting the limited effectiveness of early treatments such as alkylating agents and corticosteroids. A turning point emerged in the 1990s with the introduction of autologous stem cell transplantation, which marked the first meaningful improvement in survival outcomes. Over the following years, the development of targeted therapies—including immunomodulatory drugs and proteasome inhibitors—was associated with a more pronounced decline in mortality. These treatments introduced new mechanisms of action, such as immune modulation and enhanced cancer cell apoptosis, significantly improving disease control. More recent years have seen further progress with the introduction of monoclonal antibodies, maintenance therapies, and combination treatment strategies. Notably, the steepest decline in mortality occurred between 2021 and 2023, coinciding with the clinical adoption of advanced immunotherapies such as CAR T-cell therapies and bispecific antibodies. These treatments have shown the ability to induce deep and durable responses, even in heavily pretreated patients. “Our findings highlight the real-world impact of targeted therapies on population-level outcomes and underscore the urgent need for care models that ensure accessibility, affordability, and long-term sustainability in the era of precision oncology.” Importantly, while these therapeutic advances have improved survival, they have also introduced new challenges. Many patients now require long-term treatment, which can be associated with cumulative toxicities and a significant financial burden. In addition, access to these therapies remains uneven, influenced by geographic, socioeconomic, and healthcare system factors. Overall, this study provides a comprehensive, real-world view of how advances in cancer treatment have translated into measurable improvements in survival at the population level. At the same time, it highlights the need to ensure that these benefits are both sustainable and accessible to all patients as the field continues to evolve. DOI - https://doi.org/10.18632/oncotarget.28877 Correspondence to - Navkirat Kahlon - nkahlon@mgb.org; (ORCID: https://orcid.org/0000-0003-1115-2029) Abstract video - https://www.youtube.com/watch?v=-TNWkG9FyUo Subscribe for free publication alerts from Oncotarget - https://www.oncotarget.com/subscribe/ To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us on social media: Facebook - https://www.facebook.com/Oncotarget/ X - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/@OncotargetJournal LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Spotify - https://open.spotify.com/show/0gRwT6BqYWJzxzmjPJwtVh MEDIA@IMPACTJOURNALS.COM

Join host Emily Walsh Martin, PhD, as she hands the baton to the new co-hosts of The Issue podcast, Sanjay D’Souza, PhD, and Jason West, PhD. Listen in as the three preview some of the abstracts that will be presented at the ASGCT 2026 Annual Meeting, held May 11-15 in Boston, MA. Music: ‘Bright New Morning’ by Steven O’Brien – released under CC-BY 4.0. https://www.steven-obrien.net/Show your support for ASGCT!: https://asgct.org/membership/donateSee omnystudio.com/listener for privacy information.

Most stories of success involve resilience, faith, and a little bit of daring, and Robin Marsh's journey proves it. From a small-town girl with big dreams to a beloved news anchor and abstract artist, Robin's life is a masterclass in authenticity and purpose.Maverick Podcast // Episode 173Robin Marsh:https://www.robinmarshdesigns.comhttps://www.instagram.com/robinmarshokhttps://www.tiktok.com/@robinmarsh86Maverick Podcast:

Send us Fan MailIn Episode 87 of Application Paranoia, Colin Bell is joined by Rob Cuddy and Kris Duer to unpack the industry's growing push toward security platform consolidation.Are customers really asking for fewer tools, or are vendors shaping the narrative? Is consolidation improving security outcomes, or simply making complexity easier to explain to executives, boards, and auditors?The team also discusses AI-generated code, customer questions from the field, SAST analysis choices, data flow, false positives, and Kris's take on AI fear-based marketing.Plus: NPC streaming, Second Life hacking nostalgia, golf season, proactive SCA monitoring, and a quick preview of Colin and Kris's upcoming webinar on AI-assisted development.Webinar: Join Colin and Kris on 6 May for a discussion on how AI is changing how code gets written, trusted, validated, and approved. Register here: https://www.linkedin.com/events/7449460461881704448/

The Fall "U.S. 80s-90s" (Live) Drome "Moon On My Screen" (Dub Version) Autechre "P.I.O.B." (Mix Two) Faust "Right Between Yr Eyes" Stereolab "Percolations" Foetus "Herds" Pumice "Weird Crab Holy Soldier" John Fahey "Ghosts" The Microphones "Mount Eerie" Ksiezyc "Zakopana" Celtic Frost "Caress Into Oblivion" Scott Walker & Sunn O))) "Fetish"

Behind the scenes on Capitol Hill, concerns about personal safety, logistics and family well‑being shape how members and staff experience the job day to day. We'll take a practical look at how those very human factors affect focus, capacity, and the ability to do sustained legislative work. Danielle Stewart from the POPVOX Foundation joins me.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Things get real heady in the studio as Your Generals try to take on the sad weirdness of ABSOLUTE MARTIAN MANHUNTER by Deniz Camp and Javier Rodriguez. Check out all General Nerdery Presents... podcasts at www.gnpresents.com Email us at generalnerderypod@gmail.com

Featuring an interview with Dr Natalie Vokes, including the following topics: Perioperative minimal residual disease (MRD) detected by circulating tumor DNA (ctDNA) testing in patients with lung cancer (0:00) Ohara S et al. Clinical significance of perioperative MRD detected by ctDNA in patients with lung cancer with a long follow-up data: An exploratory study. JTO Clin Res Rep 2024;6(3):100762. Abstract Masuda K et al. MRDSEEKER (JCOG2111A): A prospective study to evaluate MRD and its association with prognosis in curative-intent NSCLC. World Conference on Lung Cancer 2025;Abstract P3.18.04.  Zhou C et al. IMpower010: Biomarkers of disease-free survival in a phase 3 study of atezolizumab vs best supportive care after adjuvant chemotherapy in stage IB-IIIA NSCLC. ESMO IO 2021;Abstract 2O. MRD analysis of adjuvant therapy with osimertinib for resected EGFR-mutated Stage IB to IIIA non-small cell lung cancer (NSCLC) (8:28) Herbst RS et al. Molecular residual disease analysis of adjuvant osimertinib in resected EGFR-mutated stage IB-IIIA non-small-cell lung cancer. Nat Med 2025;31(6):1958-68. Abstract MRD analyses of perioperative chemoimmunotherapy for resected NSCLC (15:12) Forde PM et al. Overall survival with neoadjuvant nivolumab plus chemotherapy in lung cancer. N Engl J Med 2025;393(8):741-52. Abstract  ctDNA dynamics in advanced NSCLC treated with immunotherapy (20:56) Vokes NI et al. Circulating tumor DNA (ctDNA) dynamics and survival outcomes in patients (pts) with advanced non-small cell lung cancer (aNSCLC) and high (>50%) programmed cell death ligand 1 (PD-L1) expression, randomized to cemiplimab (cemi) vs chemotherapy (chemo). ASCO 2023;Abstract 9022. Anagnostou V et al. ctDNA response after pembrolizumab in non-small cell lung cancer: Phase 2 adaptive trial results. Nat Med 2023;29(10):2559-69. Abstract Anagnostou V et al. A biomarker-directed, multi-center phase II/III study of ctDNA molecular response adaptive immuno-chemotherapy in patients with non-small cell lung cancer (BR.36). ASCO 2025;Abstract TPS8669. CME information and select publications

BUFFALO, NY – April 13, 2026 – A new #review was #published in Volume 17 of Oncotarget on March 31, 2026, titled “Cancer without borders: Policy frameworks for oncology care in humanitarian and conflict settings.” The study—led by corresponding author Pragnesh Parmar, along with Gunvanti Rathod from AIIMS Bibinagar, Telangana, India—brings together evidence from peer-reviewed studies, global health reports, and case examples from regions such as Gaza, Sudan, and Ukraine to examine the structural, ethical, and policy barriers limiting access to cancer care in humanitarian settings. Their findings show that oncology services are often excluded from emergency health priorities, resulting in delayed diagnosis, treatment interruptions, and reduced access to palliative care. The review further highlights that disrupted infrastructure, legal constraints, and fragmented policies disproportionately impact vulnerable populations—including women, children, and the elderly—who often present with advanced disease stages due to delays in care. “Addressing cancer in humanitarian contexts is not merely a technical challenge but a moral imperative.” The authors conclude that integrating oncology into humanitarian response frameworks is essential to ensure equitable access to care and improve outcomes for displaced populations. They emphasize the need for coordinated global strategies, including cross-border care models, tele-oncology, and policy reform, to address this critical gap in global health systems. DOI - https://doi.org/10.18632/oncotarget.28856 Correspondence to - Pragnesh Parmar - drprag@gmail.com; (ORCID: orcid.org/0000-0002-8402-8435) Abstract video - https://www.youtube.com/watch?v=zXlhIBZyJ6Q Sign up for free Altmetric alerts about this article - https://oncotarget.altmetric.com/details/email_updates?id=10.18632%2Foncotarget.28856 Subscribe for free publication alerts from Oncotarget - https://www.oncotarget.com/subscribe/ Keywords - cancer, cancer care, humanitarian crisis, tele-oncology, global health policy, oncology triage To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us on social media: Facebook - https://www.facebook.com/Oncotarget/ X - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/@OncotargetJournal LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Spotify - https://open.spotify.com/show/0gRwT6BqYWJzxzmjPJwtVh MEDIA@IMPACTJOURNALS.COM

Featuring perspectives from Dr Paul G Richardson, including the following topics: EXCALIBER-RRMM: A Phase III trial of iberdomide, daratumumab and dexamethasone for relapsed/refractory multiple myeloma (0:00) Lonial S et al. EXCALIBER-RRMM: A phase III trial of iberdomide, daratumumab, and dexamethasone in relapsed/refractory multiple myeloma. Future Oncol 2025;21(14):1761-9. Abstract  Phase III SUCCESSOR-1 and SUCCESSOR-2 studies evaluating mezigdomide-based regimens for relapsed/refractory multiple myeloma (8:24) Richardson PG et al. A phase III, two-stage, randomized study of mezigdomide, bortezomib, and dexamethasone (MeziVd) versus pomalidomide, bortezomib, and dexamethasone (PVd) in relapsed/refractory multiple myeloma (RRMM): SUCCESSOR-1. SOHO 2023;Abstract MM-372. Richardson PG et al. A phase 3, two-stage, randomized study of mezigdomide, carfilzomib, and dexamethasone (MeziKd) versus carfilzomib and dexamethasone (Kd) in relapsed/refractory multiple myeloma (RRMM): SUCCESSOR-2. ASCO 2023;Abstract TPS8070.  EMN26: A Phase II study of maintenance therapy with iberdomide after autologous stem-cell transplantation for newly diagnosed multiple myeloma (13:34) van de Donk NWCJ et al. Iberdomide maintenance after autologous stem-cell transplantation in newly diagnosed multiple myeloma: An update from the phase 2 EMN26 trial. ASH 2025;Abstract 101.  STOMP: A Phase I study of selinexor, mezigdomide and dexamethasone for patients with relapsed/refractory multiple myeloma who experienced relapse with or are ineligible for T-cell-redirecting therapy (24:53) Mo C et al. Selinexor, mezigdomide, and dexamethasone in patients with relapsed/refractory multiple myeloma who relapsed or are ineligible for T-cell–redirecting therapy: Stomp Phase 1 results. ASH 2025;Abstract 4010.  CME information and select publications

Livi by LiviWell is an FDA-cleared, single-use, soft polyurethane foam device designed to immediately absorb post-intercourse fluids (semen) to support vaginal health. Inserted like a tampon within 15 minutes post-coitus, it works in roughly 60 seconds to restore natural pH, helping to manage odor, dripping, and discomfort. Is this evidence-based? Listen in for details.1. https://www.biospace.com/press-releases/liviwell-secures-fda-clearance-for-livi-introducing-a-new-category-in-post-intercourse-vaginal-care#:~:text=Advertise-,LiviWell%20Secures%20FDA%20Clearance%20for%20Livi%2C%20Introducing%20a%20New%20Category,and%20other%20post%2Dintercourse%20fluids.2. Mngomezulu K, Mzobe GF, Mtshali A, et al. Recent Semen Exposure Impacts the Cytokine Response and Bacterial Vaginosis in Women. Frontiers in Immunology. 2021. 3. Abstract: ISSWSH/ISSM Joint Meeting 2025. Abstract citation ID: qdaf068.138 (155) SEMEN IS NOTTHEVAGINA'SFRIEND:ANOVEL POST-SEX TAMPON IMPROVES VAGINAL HEALTH PARAMETERS

Dr. Rukhsana Mirza sits down with Dr. Avni P. Finn to discuss her Ophthalmology Science article, "Ultra-Widefield Fundus Autofluorescence Findings as an Indicator of Duration in Rhegmatogenous Retinal Detachment," which used ultra-widefield color fundus photography and fundus autofluorescence to assess patients with rhegmatogenous retinal detachment, relating clinical features to imaging findings and comparing between the 2 imaging modalities. Ultra-Widefield Fundus Autofluorescence Findings as an Indicator of Duration in Rhegmatogenous Retinal Detachment. Zhang, David L. et al. Ophthalmology Science, Volume 6, Issue 2. Working on new research? Researchers around the world are already submitting abstracts for AAO 2026. If you're preparing a paper, poster, or video, now is the time to share it. Abstract submissions close April 14. Submit your abstract today. Visit aao.org/pod26.

This week I'm reading from Becky Ferreira's book 'First Contact: The Story of Our Obsession with Aliens' A narrative and visual exploration of humanity's age-old search for and fixation with extraterrestrials. First Contact explores the ancient idea—and epic quest to prove—that we are not alone in the universe. Presented in a heavily illustrated cabinet of curiosities format, the book explores our fascination with aliens from early history to present day, including chapters on alien conspiracy theories, aliens in science fiction, the actual science behind our search for aliens, and what happens if and when they come…or, if we are in fact descended from them. Each chapter is filled with bite-sized explainers and longer sections on meatier topics such as habitable zones, xenolinguistics, and UFO religions. Smaller topics include alien abductions, ancient astronauts, exodinosaurs, Project Cyclops, and the Great Moon Hoax. Bio Becky is a science writer based in Ithaca, New York. She is a regular contributor to the journalist-founded site 404 Media, where she writes the weekly science newsletter the Abstract. ​She has her own newsletter, The BeX Files, which covers science, culture, and more. I have bylines in The New York Times, WIRED, MIT Technology Review, National Geographic, Motherboard, Supercluster, and many more. I have appeared as an expert guest on the Science Channel and hosted the Motherboard video series "Space Show." https://www.beckyferreira.com/ https://www.amazon.com/dp/B0DSFLYV6V https://bexfiles.ghost.io/ https://www.pastliveshypnosis.co.uk/ https://www.patreon.com/alienufopodcast https://simonbown.com/ My new book, Aspects of Alien Abduction https://www.amazon.com/dp/B0GRRPCT9Y Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

This week on Unjaded, I'm pulling back the curtain on the opening of Blue Sparrow -- my new online resale shop -- and using it as a live case study in what it actually looks like to make decisions from your Human Design. Not the pretty, cleaned-up version. The real one.Because this decision took a year. One full year. And if you know anything about Manifesting Generators, you know how painful that is.We're going deep on:The emotional authority piece no one talks about -- what it means to "wait your wave" when you have more than one wave, and why one wave is almost never enough for a real decision. I walked through three emotional waves before Blue Sparrow made sense. And I'd do it again.Abstract circuitry and verbal processing -- if you go around the mulberry bush when you talk (or think, or plan), you may have abstract circuitry in your design. The 46-29 and 41-30 channels in my design mean I'm always pulling from past experience to create forward-facing insight. It's not a flaw. It's the circuitry doing its job.Your Human Design signature and your sales -- this is the part I did not expect. The moment I committed to opening Blue Sparrow, my Human Design business sales spiked. Not a coincidence. When you're satisfied (Generators and MGs), successful (Projectors), surprised and delighted (Reflectors), or at peace (Manifestors), your aura expands. You magnetize people to you. When you're frustrated, angry, bitter, or disappointed? You push them away. Full stop.Why I'm leaving the bricks and mortar -- nothing against my partner Lisa (whose undefined G Center means that location is absolutely right for her). But I'm a second line with a markets environment and an emotional authority. I felt unsettled in that space from early on. Normalizing the knowing -- even when it doesn't make logical sense -- is the work.The big rock planning method -- how I prioritized Blue Sparrow as my Q1 non-negotiable and let other things slide to make it happen. The online store opened March 25th with $7-8K in inventory and a lot of conviction.If you want to understand your own design deeply enough to make decisions like this -- with your body, not your head -- readings are still half price on the site. Grab yours herehttps://www.vickiedickson.com/human-design-readingBlue Sparrow Shop: bluesparrow.caFollow along on Instagram: @bluesparrowshopBook a Human Design Reading: https://www.vickiedickson.com/human-design-reading

The Rev. Br. Richard Edward Helmer, Precentor Grace Cathedral, San Francisco, CA Friday, April 3rd, 2026, 3p Solemn Liturgy of Good Friday Isaiah 52:13-53:12 Hebrews 4:14-16, 5:7-9 Psalm 22:1-11 John 18:1-19:42

This week I'm talking to Becky Ferreira about her book 'First Contact: The Story of Our Obsession with Aliens' A narrative and visual exploration of humanity's age-old search for and fixation with extraterrestrials. First Contact explores the ancient idea—and epic quest to prove—that we are not alone in the universe. Presented in a heavily illustrated cabinet of curiosities format, the book explores our fascination with aliens from early history to present day, including chapters on alien conspiracy theories, aliens in science fiction, the actual science behind our search for aliens, and what happens if and when they come…or, if we are in fact descended from them. Each chapter is filled with bite-sized explainers and longer sections on meatier topics such as habitable zones, xenolinguistics, and UFO religions. Smaller topics include alien abductions, ancient astronauts, exodinosaurs, Project Cyclops, and the Great Moon Hoax. Bio Becky is a science writer based in Ithaca, New York. She is a regular contributor to the journalist-founded site 404 Media, where she writes the weekly science newsletter the Abstract. ​She has her own newsletter, The BeX Files, which covers science, culture, and more. I have bylines in The New York Times, WIRED, MIT Technology Review, National Geographic, Motherboard, Supercluster, and many more. I have appeared as an expert guest on the Science Channel and hosted the Motherboard video series "Space Show." https://www.beckyferreira.com/ https://www.amazon.com/dp/B0DSFLYV6V https://bexfiles.ghost.io/ https://www.pastliveshypnosis.co.uk/ https://www.patreon.com/alienufopodcast https://simonbown.com/ My new book, Aspects of Alien Abduction https://www.amazon.com/dp/B0GRRPCT9Y Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

This week Clint speaks with Dr. Shawn McNeil & Dr. Donard.  In this conversation they explore the latest research and clinical practices in psychiatry, focusing on schizophrenia, genetic testing, early detection, and the impact of AI on mental health.    Dr. Shawn McNeil hosts an Apple podcast, "Addiction Medicine: Beyond the Abstract" Addiction Medicine: Beyond the Abstract - Podcast - Apple Podcasts. A quarterly, interactive addiction journal club was discussed, paired with presentation Dr. McNeil discusses on his podcast. https://podcasts.apple.com/us/podcast/addiction-medicine-beyond-the-abstract/id1806152019   Biography Dr. Shawn McNeil is a physician and researcher at LSU Health Shreveport. He is a Clinical Assistant Professor in the Department of Psychiatry and Behavioral Medicine and serves as Program Director of the Psychiatry Residency Program and Director of Neuroinformatics Research. He is a diplomate of the American Board of Psychiatry & Neurology and is board-certified in General Psychiatry and Child & Adolescent Psychiatry. He completed his Psychiatry residency at LSU Health Shreveport and is a recipient of the Resident Recognition Award from the American Psychiatric Association (APA). He also completed his fellowship in Child & Adolescent Psychiatry at LSU Health, serving as chief resident of the program.   Clinically, Dr. McNeil practices at Louisiana Behavioral Health where he serves as Chief Medical Officer. He also supervises residents at the Ochsner LSU Health Ambulatory Care Center. His primary research is clinical in nature. He is Principal Investigator on a clinical trial (Apathy in Schizophrenia, Intra-Cellular Therapies, Inc.) at the LSU Health Psychiatry Research Clinic which is investigating the use of Lumateperone on motivation in patients with psychotic disorders. He previously worked on the Blüm Autism Study (sponsored by Curemark) and the Tapestry Autism Study (sponsored by Axial Therapeutics). He is also the Director of Clinical Research for the Louisiana Addiction Research Center.   Dr. McNeil serves as President of the Louisiana Psychiatric Medical Association (LPMA). He is on the editorial board of the Journal of Addiction Medicine (JAM) and is host of their podcast "Addiction Medicine: Beyond the Abstract". He is a 2018 recipient of the ASAM's Ruth Fox Memorial Endowment Scholarship. He has also served on the editorial board of the APA's American Journal of Psychiatry Resident's Journal and he has been recognized as a Fellow of the APA.   Dr. McNeil was previously a staff physician at the Overton Brooks VA Medical Center and treated veterans in the Post-Traumatic Stress Disorder Clinic. He continues to proudly serve as a Deputy Coroner of Caddo Parish, Louisiana.     Donard Dwyer, PhD Professor of Psychiatry and Behavioral Medicine   Biography Donard Dwyer received his BS degree in Psychology from Tulane University, a Master's degree in education (MEd) from the University of Rochester and his PhD from the University of Alabama at Birmingham (UAB). In addition, to holding positions as a Research Scientist at the Max-Planck Society laboratories in Würzburg, Germany and Director of Immunology at a Cambridge biotechnology company, Dr. Dwyer has spent 32 years in academic research at UAB and LSU Health Shreveport. He is currently professor of Psychiatry and Pharmacology, Toxicology and Neuroscience at LSU Health Shreveport. In addition, he is Vice-Chair for Research in the Department of Psychiatry.   His research interests range broadly from the evolution of protein ligand-receptor interactions, the electronic properties of amino acids and regulation of glucose transport in neurons to behavioral genetics of motivation and movement in C. elegans and the genetic basis for schizophrenia and neuropsychiatric disorders. He is currently focused on the role of insulin signaling pathways in regulation of motivation in “suicidal” worms and characterization of the genetic architecture of schizophrenia with mathematical approaches. Finally, his laboratory is searching for drugs that produce neuroenhancement in cultured neurons as potential treatments for an array of neuropsychiatric conditions.     Medical Trial: https://www.lsuhs.edu/departments/school-of-medicine/psychiatry-and-behavioral-medicine/research   Chapters 00:00 Introduction to the Podcast and Guests 02:27 Overview of Schizophrenia and Motivation Challenges 04:23 The New Drug Adalumid Teparone and Its Potential 07:50 Understanding Schizophrenia: Causes and Risk Factors 12:04 Genetics of Schizophrenia: Myths and Realities 16:20 Enrolling Patients in Clinical Trials 20:49 Genetic Testing and Personalized Medicine in Psychiatry 25:54 Early Signs of Psychosis in Children 30:50 Supporting Families and Community Resources 40:04 The Role of AI in Future Psychiatry 52:17 AI and the Risks of Artificial Relationships 56:35 Conclusion: Hope and the Future of Mental Health Care

+Special guest.Mr. Fox has a huge announcement; Abstract reacts. Alex Isley reverence, Mr. Fox shares what new documentary he's watching. We have ideas who should sing the theme song for the sequel show to A Different World. Jarvis Butts updateMr. Fox can't believe we're here - controversial rap legend Uncle Luke is running for Congress. We discuss. Also, more about Gavin Newsome and their connection. Mr. Fox shares his thoughts on that $3 million lawsuit for social media addiction. And my message to Tommie from Baddies.

Catch an intriguing interview with Bryan Jernigan to learn about the magic behind his exhibit at Glen Echo Park in Washington, DC. https://www.bryanjernigan.com/abstraction

https://teachhoops.com/ Communicating your vision is the most important "Pre-Game" activity you will ever perform. A vision isn't just a list of goals; it is a vivid picture of a future that hasn't happened yet. If you can't describe exactly what your program will look like, sound like, and feel like in three years, you can't expect your players or community to buy in. To be effective, your vision must move from "Abstract" to "Observable." Instead of saying "We want to be a tough program," say "We will be the team that is first to the floor for every loose ball and the loudest team in the hallway before every tip-off." When you make the vision "visible," you give your athletes a specific standard to measure themselves against every single day. The second pillar of communication is "The Power of Repetition." A vision is not a "One-and-Done" speech at the parent meeting in November; it is a daily "drip." You must be the "Chief Reminding Officer" of your program. Every drill, every post-game talk, and every social media post should be filtered through your vision. If your vision is "Unselfish Excellence," then you must publicly celebrate the "Extra Pass" more than the "Crossover Layup." In the mid-season January grind, when fatigue sets in, the vision is the "Why" that keeps your players pushing through the "How." Use your TeachHoops member calls to "audit" your messaging: if you asked your 12th man what the program's vision is, could they answer you in ten seconds? Finally, you must master "The Art of the Individual Connection." While you cast a broad vision for the team, you must also communicate a "Micro-Vision" for every individual. Every player needs to know exactly how their unique "Role" contributes to the "Master Plan." When a player understands that their "bench energy" or their "defensive rebounding" is a vital organ in the body of the program, they find "Purpose in the Process." Utilize "Vision One-on-Ones"—short, 5-minute meetings where you paint a picture of who that player can become by the end of the season. By connecting their personal growth to the program's success, you create an unbreakable bond of "Shared Ownership" that lasts long after the final buzzer. Basketball vision, coaching leadership, program building, team culture, athletic leadership, high school basketball, youth basketball, basketball IQ, coach development, championship habits, "Trust Equity" in sports, coaching philosophy, character development, coach unplugged, teach hoops, basketball success, mental toughness, leadership standards, communication skills for coaches, organizational vision. SEO Keywords Learn more about your ad choices. Visit podcastchoices.com/adchoices

Primal Scream "I'm Losing More Than I'll Ever Have" Cold Sun "Here In The Year" Royal Trux "Chances Are The Comets In Our Future" Sonic Boom "Angel" B.A.L.L. "Mary Jane" The Attack "Earth Tremor" The Steppes "Hey Girl" Ant Bee "Evolution #7" Pink Floyd BBC Pig Out Spiritualized "Anyway That You Want Me"

In this celebratory episode of the Research Like a Pro podcast, Diana and Nicole highlight the incredible impact the RLP process has had on their listeners by sharing several inspiring success stories. They read comments from researchers, one of whom explains how the RLP workflows help them conquer imposter syndrome, and another who shares a journey from feeling overwhelmed as a beginner to pursuing accreditation. Multiple individuals note that the RLP method turned them from "searchers" into "researchers," providing the structure and discipline necessary to break down brick walls, and in one instance, even launch a genealogy business.  Nicole shares fun podcast statistics, including that all 400 episodes equate to 250 hours of continuous listening, and that the total downloads for each podcast episode are roughly equivalent to filling the home-side bleachers of a high school stadium. Diana and Nicole then summarize the core benefits listeners gain from applying the RLP process, which include overcoming overwhelm, building confidence to go from intermediate to professional, and staying motivated by connecting with peer groups. They conclude by discussing the profound purposes of family history, such as making new discoveries, uncovering the truth, and rescuing ancestors from anonymity, which ultimately helps listeners connect with the past and preserve their family's stories for future generations. Listeners learn how to be more productive and disciplined and how the RLP process provides the confidence and structure needed to advance their genealogical research. This summary was generated by Google Gemini. Links Episode 1 from seven and a half years ago, July 16, 2018 - https://familylocket.com/rlp-1-introduction/ Top Ten Most Downloaded Episodes of RLP RLP 185: Revisiting Timelines and Analysis Again – 6,047 - https://familylocket.com/rlp-185-revisiting-timelines-and-analysis-again/ RLP 184: Revisiting Research Objectives Again – 5,872 - https://familylocket.com/rlp-184-revisiting-research-objectives-again/ RLP 186: Revisiting Locality Research Again – 5,820 - https://familylocket.com/rlp-186-revisiting-locality-research-again/ RLP 190: Revisiting Report Writing Again – 5,762 - https://familylocket.com/rlp-190-revisiting-report-writing-again/ RLP 156: Tracing 19th Century Germans with Heidi Mathis... – 5,692 - https://familylocket.com/rlp-156-tracing-19th-century-germans-part-1-the-nitty-gritty-of-german-names/ RLP 2: Research Objectives – 5,690 - https://familylocket.com/rlp-2-research-objectives/ RLP 1: Introduction – 5,665 - https://familylocket.com/rlp-1-introduction/ RLP 158: RLP with DNA Course with Allison Part 1 – 5,660 - https://familylocket.com/rlp-158-rlp-with-dna-ecourse-part-1/ RLP 100: Top Ten Tips to Research Like a Pro – 5,610 - https://familylocket.com/rlp-100-top-ten-tips-to-research-like-a-pro/ RLP 197: Proving Your Pedigree with DNA with Debra Hoffman – 5,606 - https://familylocket.com/rlp-197-proving-your-pedigree-with-dna-with-debra-hoffman/ Upcoming Conferences NGS GenTech Toolbox workshop by Nicole - Transcribing Handwritten Documents with Artificial Intelligence - https://www.ngsgenealogy.org/gentechtoolbox/transcribing-handwritten-documents-with-ai/ North Carolina Genealogical Society Virtual Conference March 27 – Using AI to Abstract 19th Century North Carolina Deeds by Nicole - https://www.ncgenealogy.org/event/2026-ncgs-virtual-conference/  National Genealogical Society Conference May 27-30 in Fort Wayne, Indiana - https://conference.ngsgenealogy.org/ - Nicole & Diana are giving several lectures on using AI to understand terminology, Barsheba Tharp DNA case, deciphering handwriting, court records, and finding females in court records. Sponsor – Newspapers.com For listeners of this podcast, Newspapers.com is offering new subscribers 20% off a Publisher Extra subscription so you can start exploring today. Just use the code "FamilyLocket" at checkout.  Research Like a Pro Resources Airtable Universe - Nicole's Airtable Templates - https://www.airtable.com/universe/creator/usrsBSDhwHyLNnP4O/nicole-dyer Airtable Research Logs Quick Reference - by Nicole Dyer - https://familylocket.com/product-tag/airtable/ Research Like a Pro: A Genealogist's Guide book by Diana Elder with Nicole Dyer on Amazon.com - https://amzn.to/2x0ku3d 14-Day Research Like a Pro Challenge Workbook - digital - https://familylocket.com/product/14-day-research-like-a-pro-challenge-workbook-digital-only/ and spiral bound - https://familylocket.com/product/14-day-research-like-a-pro-challenge-workbook-spiral-bound/ Research Like a Pro Webinar Series - monthly case study webinars including documentary evidence and many with DNA evidence - https://familylocket.com/product-category/webinars/ Research Like a Pro eCourse - independent study course -  https://familylocket.com/product/research-like-a-pro-e-course/ RLP Study Group - upcoming group and email notification list - https://familylocket.com/services/research-like-a-pro-study-group/ Research Like a Pro Institute Courses - https://familylocket.com/product-category/institute-course/ Research Like a Pro with DNA Resources Research Like a Pro with DNA: A Genealogist's Guide to Finding and Confirming Ancestors with DNA Evidence book by Diana Elder, Nicole Dyer, and Robin Wirthlin - https://amzn.to/3gn0hKx Research Like a Pro with DNA eCourse - independent study course -  https://familylocket.com/product/research-like-a-pro-with-dna-ecourse/ RLP with DNA Study Group - upcoming group and email notification list - https://familylocket.com/services/research-like-a-pro-with-dna-study-group/ Thank you Thanks for listening! We hope that you will share your thoughts about our podcast and help us out by doing the following: Write a review on iTunes or Apple Podcasts. If you leave a review, we will read it on the podcast and answer any questions that you bring up in your review. Thank you! Leave a comment in the comment or question in the comment section below. Share the episode on Twitter, Facebook, or Pinterest. Subscribe on iTunes or your favorite podcast app. Sign up for our newsletter to receive notifications of new episodes - https://familylocket.com/sign-up/ Check out this list of genealogy podcasts from Feedspot: Best Genealogy Podcasts - https://blog.feedspot.com/genealogy_podcasts/

Tom and Zee take a look at four new abstract games in a rapid-fire manner!

In this episode, we dive deep into ASH 2025 updates on myeloid malignancies with Dr. Curtis Lachowiez. From the plenary halls of ASH 2025 to long-term follow-up of Aza/Ven/Gilteritinib, we unpack what the latest evidence means for the future of AML management.1. PARADIGM Trial (Plenary Session, Abstract 6)Fathi A, Perl A, Fell G, et al. Results from PARADIGM – a phase 2 randomized multi-center study comparing azacitidine and venetoclax to conventional induction chemotherapy for newly diagnosed fit adults with acute myeloid leukemia. Blood 2025;146(Suppl 1):6.https://doi.org/10.1182/blood-2025-6ClinicalTrials.gov: NCT048017972. VICEROY Study – Aza/Ven/Gilteritinib Triplet (Abstract 654)Venetoclax (VEN) and azacitidine (AZA) with gilteritinib (GILT) in patients with newly diagnosed FLT3mut+ AML ineligible for intensive induction chemotherapy: Interim results from the phase 1/2 VICEROY study. Blood 2025;146(Suppl 1):654.ClinicalTrials.gov: NCT055205673. Long-Term Follow-Up of Aza/Ven/Gilteritinib in FLT3-Mutated AML (Abstract 45)Azevedo RS, et al. Long-term follow-up of azacitidine, venetoclax, and gilteritinib in patients with newly diagnosed FLT3-mutated acute myeloid leukemia. Blood 2025;146(Suppl 1):45.Original publication: Short NJ, Daver N, DiNardo CD, et al. J Clin Oncol 2024;42:1499–1508. https://doi.org/10.1200/JCO.23.01911ClinicalTrials.gov: NCT041404874. PRISM-AML Score (Abstract 453)Lachowiez CA, et al. Prognostic risk integration for survival modeling (PRISM) in newly diagnosed acute myeloid leukemia treated with venetoclax: A multinational retrospective cohort study. Blood 2025;146(Suppl 1):453.Interactive Calculator: https://prism-aml.com5. Additional Studies Referenced in Discussion•       VIALE-A Trial: DiNardo CD, et al. Azacitidine and venetoclax in previously untreated acute myeloid leukemia. N Engl J Med 2020;383:617–629. (NCT02993523)•       VERONA Trial: Randomized study of Aza-Ven vs. Aza vs. placebo in MDS (discussed as a negative study)•       4-Gene Classifier (mPRS): Bataller A, et al. Prognostic risk signature in patients with AML treated with HMA and venetoclax. Blood Adv 2024;8(4):927–935. https://doi.org/10.1182/bloodadvances.2023011757•       LACEWING Trial: Azacitidine plus gilteritinib vs. azacitidine plus placebo in FLT3-mutated AML (discussed as a negative study) 

Review of Patrick Q. Mason and J. David Pulsipher, Proclaim Peace: The Restoration's Answer to an Age of Conflict (Provo, UT: Neal A. Maxwell Institute for Religious Scholarship, Brigham Young University; Salt Lake City: Deseret Book, 2021). 290 pages. $19.99 (paperback). Abstract: Proclaim Peace is a very timely and serious engagement with questions of peace. Consisting of roughly equal parts challenging scriptural exegesis, well-documented historical research, and earnest social activism, it may be taken as exemplary of current LDS academic opinion and institutional action on the interface between religion and politics. This work compels us to consider a critical question: Do we interpret the core meaning of peace as a temporal project of seeking justice? Or do we understand, contextualize, and moderate our passion for temporal justice relative to a promise of eternal peace? If we are intent on unifying heaven and earth, we should be careful from which direction we are working. The post Where Will We Turn for Peace? first appeared on The Interpreter Foundation.

In this episode, we welcome back Jeff Arnold, Founder of Leadership Adventures, for a powerful conversation about what it really takes to build the next generation of leaders in the EAS industry. Expect to here more on:When we talk about “next generation leaders,” we're talking about all of us. What the Next Generation of EAL Leaders Actually WantsAfter surveying and working with more than 60 centers, Jeff and his team have identified clear patterns in what emerging leaders are looking for:Clear expectations (at both the big-picture and daily-task level)Coaching and developmental feedbackDefined growth paths and career planningAuthentic community and collaborationCuriosity builds engagement. Judgment shuts it down.Staying Resilient Leadership in a Changing World. With leadership transitions happening across 20-, 30-, and 40-year-old centers, resilience isn't optional—it's essential.Resources:The EAL Community of Practice Jeff shares more about the growing EAL Community of Practice, an online professional space designed for collaboration, CEUs, shared learning, and authentic dialogue across methodologies. Learn more at:   equineassistedlearning.org2026 EAL Summit – Learn. Share. Lead. The next EAL Summit will take place in November 2026 in the Western Pennsylvania mountains. Abstract submissions are open now through mid-to-late March. More details:  equineassistedlearning.orgListen to the NJAPR episode 87 with Jeff here:  https://open.spotify.com/episode/1jzeTIwz1WIFKQ4bZoxyFA?si=Rmi3hLc3Qjyr4NSr14CcwAJoin us for HETRA University Live online or in person March 6-7:   https://hetrauniversity.mykajabi.com/HULStridesForward  

Cheri Carandanis, an abstract painter and former Air Force critical care nurse, shared her journey from pre-med studies to nursing, driven by her desire to balance career and family. She transitioned to the military, specializing in ICU and CCAT teams, and served in Afghanistan post-9/11. After separating from the military, she pursued hospice nursing and earned a master's degree in nursing. In 2019, she suffered two brain injuries, leading to cognitive and vestibular issues, forcing her to retire her nursing license. Through functional neurology and alternative therapies, she recovered significantly, emphasizing the importance of creativity and mindfulness in healing. For the transcript and full story go to: https://www.drmanonbolliger.com/cheri-carandanis  Highlights from today's episode include:  When I paint, I don't have a brain injury." – Abstract art and flow state became a powerful part of her neurological and emotional healing after two brain injuries. "If you've seen one healing, you've seen one healing." – Every healing journey is unique, and creativity, intuition, and somatic work can open paths that conventional medicine alone often can't. "Nothing's really broken; it's just not communicating how it should." – The body often needs a reset, not a label, and approaches like Bowen and other body-centered work help "reboot" the nervous system so healing can happen.   ABOUT CHERI CARANDANIS: Cheri Carandanis is an abstract painter, mixed media artist, and former Air Force Critical Care nurse who knows a thing or two about surviving what she never saw coming. After a traumatic brain injury ended her 25-year nursing career, she turned to art…not as a hobby, but as a lifeline. Now based in Portland, Oregon, Cheri creates raw, emotionally layered work that invites connection and contemplation. Her paintings don't try to explain everything—instead, they hold space for what's been broken, unraveled, and rebuilt. Through texture, color, and bold mark-making, she explores themes of healing, resilience, and the beauty that often shows up after the fall. Her story is one of reinvention, grit, and choosing creativity when everything else falls away. Core purpose/passion: My core purpose is to create space for truth, the kind that lives in the body, not just the story. I'm passionate about art as a place where people can slow down, feel what they've been avoiding, and come back to themselves without being fixed or explained. I care about honest healing, not performative healing, and about beauty that holds weight, not escape. My work invites presence, courage, and staying with what's real. Website | Facebook | Instagram | YouTube |  ABOUT MANON BOLLIGER, RBHT, FCAH: As a retired Naturopath 1992-2021, I saw an average of 150 patients per week and have helped people ranging from rural farmers in Nova Scotia to stressed out CEOs in Toronto to tri-athletes here in Vancouver. My resolve to educate, empower and engage people to take charge of their own health is evident in my best-selling books:  'What Patients Don't Say if Doctors Don't Ask: The Mindful Patient-Doctor Relationship' and 'A Healer in Every Household: Simple Solutions for Stress'. and What if Your Body is Smarter than You Think?  I am the Founder & CEO of The Bowen College Inc. which teaches BowenFirst™ Therapy and holds transformational workshops to achieve these goals. So, when I share with you that LISTENing to Your body is a game changer in the healing process, I am speaking from expertise and direct experience". Mission: A Healer in Every Household! For more great information to go to her weekly blog:  http://bowencollege.com/blog.  For tips on health & healing go to: https://www.drmanonbolliger.com/tips Follow: Manon Bolliger website  | Linktr.ee | Rumble | Gettr  | Facebook | Instagram | YouTube | Twitter | LinkedIn | Follow: Bowen College Inc. | Facebook | Instagram  | LinkedIn | YouTube | Twitter | Rumble | Locals ABOUT THE HEALERS CAFE: Manon's show is the #1 show for medical practitioners and holistic healers to have heart to heart conversations about their day to day lives. Subscribe and review on your favourite platform: iTunes | Google Play | Spotify | Libsyn | iHeartRadio | Gaana | The Healers Cafe | Radio.com | Medioq | Audacy | Follow The Healers Café on FB: https://www.facebook.com/thehealerscafe   Remember to subscribe if you like our videos. Click the bell if you want to be one of the first people notified of a new release.   * De-Registered, revoked & retired naturopathic physician after 30 years of practice in healthcare. Now resourceful & resolved to share with you all the tools to take care of your health & vitality!

In this engaging conversation, Kavin Chawla shares his journey as an abstract photographer, discussing how his upbringing in Thailand and experiences in nature have shaped his artistic vision. He emphasizes the importance of curiosity, playfulness, and embracing imperfection in photography. Kavin also reflects on the meditative aspects of being in nature and how it influences his creative process. He encourages aspiring photographers to stay true to their unique vision while drawing inspiration from others. As he prepares to launch his website, Kavin contemplates how to present his work authentically, moving away from conventional styles. The discussion concludes with recommendations for fellow photographers who embody similar values in their work. Links and Recommended Photographers: Kavin Chawla: Instagram Support the show on Patreon The Colorado Way book Natural Landscape Photography Awards (NLPA) Richard Martin: Wabi Sabi gallery Brent Clark's Website Michael Shainblum David Southern Robert Hecht: Instagram Jack Krohn: Instagram Scott Oller: Instagram Eric Bennett Matt Payne / Sean Tucker: Podcast Brooks Jensen: LensWork Erik Malm: Instagram